SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLDX Celldex Therapeudics
CLDX 24.68-0.3%12:07 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche1/15/2019 11:12:09 AM
   of 105
 
Just parking, a tickle to follow up. Nothing to see here.....

Immunol Cell Biol. 2018 Mar;96(3):298-315. doi: 10.1111/imcb.12003. Epub 2018 Jan 18.

Crucial role of Mer tyrosine kinase in the maintenance of SIGN-R1+ marginal zone macrophages.

Soni C1, Schell SL1, Fasnacht MJ1, Chodisetti SB1, Rahman ZS1.

1
Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.

Mer Tyrosine Kinase receptor (Mer) is involved in anti-inflammatory efferocytosis. Here we report elevated spontaneous germinal center (Spt-GC) responses in Mer-deficient mice (Mer-/- ) that are associated with the loss of SIGN-R1+ marginal zone macrophages (MZMs). The dissipation of MZMs in Mer-/- mice occurs independently of reduced cellularity or delocalization of marginal zone B cells, sinusoidal cells or of CD169+ metallophillic macrophages. We find that MZM dissipation in Mer-/- mice contributes to apoptotic cell (AC) accumulation in Spt-GCs and dysregulation of the GC checkpoint, allowing an expansion of DNA-reactive B cells in GCs. We further observe that bone marrow derived macrophages from Mer-/- mice produce more TNFa, and are susceptible to cell death upon exposure to ACs compared to WT macrophages. Anti-TNFa Ab treatment of Mer-/- mice is, however, unable to reverse MZM loss, but results in reduced Spt-GC responses, indicating that TNFa promotes Spt-GC responses in Mer-/- mice. Contrary to an anti-TNFa Ab treatment, treatment of Mer-/- mice with a synthetic agonist for the transcription factor LXRa rescues a significant number of MZMs in vivo. Our data suggest that Mer-LXRa signaling plays an important role in the differentiation and maintenance of MZMs, which in turn regulate Spt-GC responses and tolerance.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext